Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.

228.97 2.53 −1.09%
Market cap
$162.7B
P/E
40.5×
Fwd P/E
29.2×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

40.63 45.15 36.53 33.71
P/S ratio
5.81 6.64 5.42 5.35
P/FCF ratio
28.02 30.82 25.24 24.48
P/Operating CF
84.78 77.07 101.53 87.58
P/B ratio
2.76 3.11 2.53 2.55
EV/Sales
6.44 7.20 5.90 6.18
EV/EBITDA
22.21 24.79 20.17 20.14
EV/FCF
31.07 33.43 27.47 28.26
Current Ratio
1.52 1.87 1.87 1.65
Net Debt/EBITDA
8.62 6.49 6.02 11.35
Debt/Equity
0.33 0.35 0.33 0.48
Earnings Yield
2.46% 2.21% 2.74% 2.97%
Free Cash Flow Yield
3.57% 3.24% 3.96% 4.09%
Free Cash Flow per Share
1.93 2.48 1.53 1.79
Book value per Share
71.87 73.72 74.81 74.57
Free Cash Flow
1,370.00 1,769.00 1,085.00 1,265.00
EV/EBIT
33.86 37.73 30.69 30.26
Other line items

Show all line items

Columns are period end dates